Desarrollo De Un Nanocompuesto Fe3o4@Sio2 Como Potencial Nanotrasportador De Fármacos Para El Tratamiento Contra El Glioblastoma Multiforme
Among all the treatments for glioblastoma multiforme, chemotherapy is the most widespread because of anticancer drugs, which help shrink the tumor. Unfortunately, these drugs present several problems, such as the resistance of cancer cells and their low specificity. Using nanocarriers of these drugs...
- Autores:
-
Montero Vásquez, José Miguel
- Tipo de recurso:
- Trabajo de grado de pregrado
- Fecha de publicación:
- 2023
- Institución:
- Universidad Antonio Nariño
- Repositorio:
- Repositorio UAN
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.uan.edu.co:123456789/8255
- Acceso en línea:
- http://repositorio.uan.edu.co/handle/123456789/8255
- Palabra clave:
- Nanocompuesto
Superparamagnetico
Ultrasonidos
Glioblastoma multiforme
Citotoxicidad
574
38.23 M778d
Nanocomposite
superparamagnetic
Ultrasonidos
Glioblastoma multiforme
Cytotoxicity
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
| Summary: | Among all the treatments for glioblastoma multiforme, chemotherapy is the most widespread because of anticancer drugs, which help shrink the tumor. Unfortunately, these drugs present several problems, such as the resistance of cancer cells and their low specificity. Using nanocarriers of these drugs is a novel strategy that can reduce the side effects associated with chemotherapy and thus obtain treatment with a lower burden on the body. |
|---|